查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1721211

臨床試驗外包市場－全球產業分析、規模、佔有率、成長、趨勢及預測（2025-2035）

Clinical Trials Outsourcing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035
出版日期: | 出版商: Transparency Market Research | 英文 213 Pages | 商品交期: 2-10個工作天內

價格

臨床試驗外包市場-報告範圍

TMR 關於全球臨床試驗外包市場的報告研究了過去和當前的成長趨勢和機會，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2019 年至 2035 年期間全球臨床試驗外包市場的收入，以 2025 年為基準年，2035 年為預測年。該報告也提供了2025年至2035年全球臨床試驗外包市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初步研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了訪談。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解臨床試驗外包市場。

市場概況
2024 年的市場價值 507億美元
2035年的市場價值 1019億美元
複合年成長率 6.4%

該報告深入探討了全球臨床試驗外包市場的競爭格局。我們已經確定了在全球臨床試驗外包市場中運作的關鍵參與者，並根據各種屬性對每個參與者進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告介紹的全球臨床試驗外包市場參與者的屬性。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概覽

  • 介紹
  • 概述
  • 市場動態
  • 2020-2035年全球臨床試驗外包市場分析與預測

第5章：關鍵見解

  • 重要產業活動
  • 影響分析
  • PESTEL分析
  • 主要國家/地區監管情況
  • 波特五力分析
  • 技術進步
  • 融資/投資方案

第6章：全球市場分析與預測：依服務類型

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：依服務類型，2020-2035
    • 實驗室服務
    • 生物分析測試服務
    • 分散臨床試驗服務
    • 病患招募
    • 場地識別
    • 分析測試服務
    • 臨床試驗供應和物流服務
    • 協議設計
    • 臨床試驗資料管理服務
    • 醫療器材測試服務
    • 其他
  • 市場吸引力分析：按服務類型

第7章：全球市場分析與預測：依治療領域

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：依治療領域，2020-2035
    • 腫瘤學
    • 傳染病
    • 神經病學
    • 代謝紊亂
    • 免疫學
    • 心臟病學
    • 遺傳疾病
    • 女性健康
    • 其他
  • 市場吸引力分析：按治療領域

第8章：全球市場分析與預測：按應用

  • 介紹與定義
  • 主要發現/進展
  • 市場價值預測：按應用，2020-2035
    • 小分子
    • 單株抗體
    • 疫苗
    • 細胞與基因治療
    • 其他
  • 市場吸引力分析：按應用

第9章：全球市場分析與預測：按最終用戶

  • 介紹和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2020-2035
    • 製藥和生物技術公司
    • 醫療器材製造商
  • 市場吸引力分析：按最終用戶

第10章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2020-2035
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第 11 章：北美市場分析與預測

第12章：歐洲市場分析與預測

第13章：亞太市場分析與預測

第14章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第 16 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：按公司（2024年）
  • 公司簡介
    • ICON plc
    • IQVIA
    • Thermo Fisher Scientific Inc.
    • SGS Life Sciences
    • Charles River Laboratories
    • Parexel
    • Syneos Health
    • Medpace
    • LabCorp
    • KCR
    • PRA Health Sciences
    • WuXi AppTec
    • Pharmaron
    • Avance Clinical
    • Pharmaron
Product Code: TMRGL86540

Clinical Trials Outsourcing Market - Scope of Report

TMR's report on the global clinical trials outsourcing market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global clinical trials outsourcing market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global clinical trials outsourcing market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the clinical trials outsourcing market.

Market Snapshot
Market Value in 2024US$ 50.7 Bn
Market Value in 2035US$ 101.9 Bn
CAGR6.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global clinical trials outsourcing market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global clinical trials outsourcing market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global clinical trials outsourcing market.

The report delves into the competitive landscape of the global clinical trials outsourcing market. Key players operating in the global clinical trials outsourcing market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global clinical trials outsourcing market profiled in this report.

Key Questions Answered in Global clinical trials outsourcing market Report:

  • What is the sales/revenue generated by clinical trials outsourcing across all regions during the forecast period?
  • What are the opportunities in the global clinical trials outsourcing market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Clinical Trials Outsourcing Market - Research Objectives and Research Approach

The comprehensive report on the global clinical trials outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global clinical trials outsourcing market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global clinical trials outsourcing market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Clinical Trials Outsourcing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Clinical Trials Outsourcing Market Analysis and Forecast, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Key Industry Events
  • 5.2. Impact Analysis
  • 5.3. PESTEL Analysis
  • 5.4. Regulatory Scenario by Key Countries/Regions
  • 5.5. PORTER's Five Forces Analysis
  • 5.6. Technological Advancements
  • 5.7. Fund Raise/Investment Scenario

6. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Service Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Service Type, 2020-2035
    • 6.3.1. Laboratory Services
    • 6.3.2. Bioanalytical Testing Services
    • 6.3.3. Decentralized Clinical Trial Services
    • 6.3.4. Patient Recruitment
    • 6.3.5. Site Identification
    • 6.3.6. Analytical Testing Services
    • 6.3.7. Clinical Trial Supply & Logistic Services
    • 6.3.8. Protocol Designing
    • 6.3.9. Clinical Trial Data Management Services
    • 6.3.10. Medical Device Testing Services
    • 6.3.11. Others
  • 6.4. Market Attractiveness Analysis, by Service Type

7. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Therapeutic Area

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 7.3.1. Oncology
    • 7.3.2. Infectious Diseases
    • 7.3.3. Neurology
    • 7.3.4. Metabolic Disorders
    • 7.3.5. Immunology
    • 7.3.6. Cardiology
    • 7.3.7. Genetic Diseases
    • 7.3.8. Women's Health
    • 7.3.9. Others
  • 7.4. Market Attractiveness Analysis, by Therapeutic Area

8. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2020-2035
    • 8.3.1. Small Molecules
    • 8.3.2. Monoclonal Antibodies
    • 8.3.3. Vaccine
    • 8.3.4. Cell & Gene Therapy
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Clinical Trials Outsourcing Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2020-2035
    • 9.3.1. Pharmaceutical and Biotech Companies
    • 9.3.2. Medical Device Manufacturers
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Clinical Trials Outsourcing Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2035
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Region

11. North America Clinical Trials Outsourcing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Service Type, 2020-2035
    • 11.2.1. Laboratory Services
    • 11.2.2. Bioanalytical Testing Services
    • 11.2.3. Decentralized Clinical Trial Services
    • 11.2.4. Patient Recruitment
    • 11.2.5. Site Identification
    • 11.2.6. Analytical Testing Services
    • 11.2.7. Clinical Trial Supply & Logistic Services
    • 11.2.8. Protocol Designing
    • 11.2.9. Clinical Trial Data Management Services
    • 11.2.10. Medical Device Testing Services
    • 11.2.11. Others
  • 11.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 11.3.1. Oncology
    • 11.3.2. Infectious Diseases
    • 11.3.3. Neurology
    • 11.3.4. Metabolic Disorders
    • 11.3.5. Immunology
    • 11.3.6. Cardiology
    • 11.3.7. Genetic Diseases
    • 11.3.8. Women's Health
    • 11.3.9. Others
  • 11.4. Market Value Forecast, by Application, 2020-2035
    • 11.4.1. Small Molecules
    • 11.4.2. Monoclonal Antibodies
    • 11.4.3. Vaccine
    • 11.4.4. Cell & Gene Therapy
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by End-user, 2020-2035
    • 11.5.1. Pharmaceutical and Biotech Companies
    • 11.5.2. Medical Device Manufacturers
  • 11.6. Market Value Forecast, by Country, 2020-2035
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Service Type
    • 11.7.2. By Therapeutic Area
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Clinical Trials Outsourcing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Service Type, 2020-2035
    • 12.2.1. Laboratory Services
    • 12.2.2. Bioanalytical Testing Services
    • 12.2.3. Decentralized Clinical Trial Services
    • 12.2.4. Patient Recruitment
    • 12.2.5. Site Identification
    • 12.2.6. Analytical Testing Services
    • 12.2.7. Clinical Trial Supply & Logistic Services
    • 12.2.8. Protocol Designing
    • 12.2.9. Clinical Trial Data Management Services
    • 12.2.10. Medical Device Testing Services
    • 12.2.11. Others
  • 12.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 12.3.1. Oncology
    • 12.3.2. Infectious Diseases
    • 12.3.3. Neurology
    • 12.3.4. Metabolic Disorders
    • 12.3.5. Immunology
    • 12.3.6. Cardiology
    • 12.3.7. Genetic Diseases
    • 12.3.8. Women's Health
    • 12.3.9. Others
  • 12.4. Market Value Forecast, by Application, 2020-2035
    • 12.4.1. Small Molecules
    • 12.4.2. Monoclonal Antibodies
    • 12.4.3. Vaccine
    • 12.4.4. Cell & Gene Therapy
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by End-user, 2020-2035
    • 12.5.1. Pharmaceutical and Biotech Companies
    • 12.5.2. Medical Device Manufacturers
  • 12.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 12.6.1. Germany
    • 12.6.2. UK
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Service Type
    • 12.7.2. By Therapeutic Area
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Clinical Trials Outsourcing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Service Type, 2020-2035
    • 13.2.1. Laboratory Services
    • 13.2.2. Bioanalytical Testing Services
    • 13.2.3. Decentralized Clinical Trial Services
    • 13.2.4. Patient Recruitment
    • 13.2.5. Site Identification
    • 13.2.6. Analytical Testing Services
    • 13.2.7. Clinical Trial Supply & Logistic Services
    • 13.2.8. Protocol Designing
    • 13.2.9. Clinical Trial Data Management Services
    • 13.2.10. Medical Device Testing Services
    • 13.2.11. Others
  • 13.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 13.3.1. Oncology
    • 13.3.2. Infectious Diseases
    • 13.3.3. Neurology
    • 13.3.4. Metabolic Disorders
    • 13.3.5. Immunology
    • 13.3.6. Cardiology
    • 13.3.7. Genetic Diseases
    • 13.3.8. Women's Health
    • 13.3.9. Others
  • 13.4. Market Value Forecast, by Application, 2020-2035
    • 13.4.1. Small Molecules
    • 13.4.2. Monoclonal Antibodies
    • 13.4.3. Vaccine
    • 13.4.4. Cell & Gene Therapy
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by End-user, 2020-2035
    • 13.5.1. Pharmaceutical and Biotech Companies
    • 13.5.2. Medical Device Manufacturers
  • 13.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Service Type
    • 13.7.2. By Therapeutic Area
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Clinical Trials Outsourcing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Service Type, 2020-2035
    • 14.2.1. Laboratory Services
    • 14.2.2. Bioanalytical Testing Services
    • 14.2.3. Decentralized Clinical Trial Services
    • 14.2.4. Patient Recruitment
    • 14.2.5. Site Identification
    • 14.2.6. Analytical Testing Services
    • 14.2.7. Clinical Trial Supply & Logistic Services
    • 14.2.8. Protocol Designing
    • 14.2.9. Clinical Trial Data Management Services
    • 14.2.10. Medical Device Testing Services
    • 14.2.11. Others
  • 14.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 14.3.1. Oncology
    • 14.3.2. Infectious Diseases
    • 14.3.3. Neurology
    • 14.3.4. Metabolic Disorders
    • 14.3.5. Immunology
    • 14.3.6. Cardiology
    • 14.3.7. Genetic Diseases
    • 14.3.8. Women's Health
    • 14.3.9. Others
  • 14.4. Market Value Forecast, by Application, 2020-2035
    • 14.4.1. Small Molecules
    • 14.4.2. Monoclonal Antibodies
    • 14.4.3. Vaccine
    • 14.4.4. Cell & Gene Therapy
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by End-user, 2020-2035
    • 14.5.1. Pharmaceutical and Biotech Companies
    • 14.5.2. Medical Device Manufacturers
  • 14.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Service Type
    • 14.7.2. By Therapeutic Area
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Clinical Trials Outsourcing Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Service Type, 2020-2035
    • 15.2.1. Laboratory Services
    • 15.2.2. Bioanalytical Testing Services
    • 15.2.3. Decentralized Clinical Trial Services
    • 15.2.4. Patient Recruitment
    • 15.2.5. Site Identification
    • 15.2.6. Analytical Testing Services
    • 15.2.7. Clinical Trial Supply & Logistic Services
    • 15.2.8. Protocol Designing
    • 15.2.9. Clinical Trial Data Management Services
    • 15.2.10. Medical Device Testing Services
    • 15.2.11. Others
  • 15.3. Market Value Forecast, by Therapeutic Area, 2020-2035
    • 15.3.1. Oncology
    • 15.3.2. Infectious Diseases
    • 15.3.3. Neurology
    • 15.3.4. Metabolic Disorders
    • 15.3.5. Immunology
    • 15.3.6. Cardiology
    • 15.3.7. Genetic Diseases
    • 15.3.8. Women's Health
    • 15.3.9. Others
  • 15.4. Market Value Forecast, by Application, 2020-2035
    • 15.4.1. Small Molecules
    • 15.4.2. Monoclonal Antibodies
    • 15.4.3. Vaccine
    • 15.4.4. Cell & Gene Therapy
    • 15.4.5. Others
  • 15.5. Market Value Forecast, by End-user, 2020-2035
    • 15.5.1. Pharmaceutical and Biotech Companies
    • 15.5.2. Medical Device Manufacturers
  • 15.6. Market Value Forecast, by Country/Sub-region, 2020-2035
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Service Type
    • 15.7.2. By Therapeutic Area
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Market Share Analysis, by Company (2024)
  • 16.3. Company Profiles
    • 16.3.1. ICON plc
      • 16.3.1.1. Company Overview
      • 16.3.1.2. Financial Overview
      • 16.3.1.3. Product Portfolio
      • 16.3.1.4. Business Strategies
      • 16.3.1.5. Recent Developments
    • 16.3.2. IQVIA
      • 16.3.2.1. Company Overview
      • 16.3.2.2. Financial Overview
      • 16.3.2.3. Product Portfolio
      • 16.3.2.4. Business Strategies
      • 16.3.2.5. Recent Developments
    • 16.3.3. Thermo Fisher Scientific Inc.
      • 16.3.3.1. Company Overview
      • 16.3.3.2. Financial Overview
      • 16.3.3.3. Product Portfolio
      • 16.3.3.4. Business Strategies
      • 16.3.3.5. Recent Developments
    • 16.3.4. SGS Life Sciences
      • 16.3.4.1. Company Overview
      • 16.3.4.2. Financial Overview
      • 16.3.4.3. Product Portfolio
      • 16.3.4.4. Business Strategies
      • 16.3.4.5. Recent Developments
    • 16.3.5. Charles River Laboratories
      • 16.3.5.1. Company Overview
      • 16.3.5.2. Financial Overview
      • 16.3.5.3. Product Portfolio
      • 16.3.5.4. Business Strategies
      • 16.3.5.5. Recent Developments
    • 16.3.6. Parexel
      • 16.3.6.1. Company Overview
      • 16.3.6.2. Financial Overview
      • 16.3.6.3. Product Portfolio
      • 16.3.6.4. Business Strategies
      • 16.3.6.5. Recent Developments
    • 16.3.7. Syneos Health
      • 16.3.7.1. Company Overview
      • 16.3.7.2. Financial Overview
      • 16.3.7.3. Product Portfolio
      • 16.3.7.4. Business Strategies
      • 16.3.7.5. Recent Developments
    • 16.3.8. Medpace
      • 16.3.8.1. Company Overview
      • 16.3.8.2. Financial Overview
      • 16.3.8.3. Product Portfolio
      • 16.3.8.4. Business Strategies
      • 16.3.8.5. Recent Developments
    • 16.3.9. LabCorp
      • 16.3.9.1. Company Overview
      • 16.3.9.2. Financial Overview
      • 16.3.9.3. Product Portfolio
      • 16.3.9.4. Business Strategies
      • 16.3.9.5. Recent Developments
    • 16.3.10. KCR
      • 16.3.10.1. Company Overview
      • 16.3.10.2. Financial Overview
      • 16.3.10.3. Product Portfolio
      • 16.3.10.4. Business Strategies
      • 16.3.10.5. Recent Developments
    • 16.3.11. PRA Health Sciences
      • 16.3.11.1. Company Overview
      • 16.3.11.2. Financial Overview
      • 16.3.11.3. Product Portfolio
      • 16.3.11.4. Business Strategies
      • 16.3.11.5. Recent Developments
    • 16.3.12. WuXi AppTec
      • 16.3.12.1. Company Overview
      • 16.3.12.2. Financial Overview
      • 16.3.12.3. Product Portfolio
      • 16.3.12.4. Business Strategies
      • 16.3.12.5. Recent Developments
    • 16.3.13. Pharmaron
      • 16.3.13.1. Company Overview
      • 16.3.13.2. Financial Overview
      • 16.3.13.3. Product Portfolio
      • 16.3.13.4. Business Strategies
      • 16.3.13.5. Recent Developments
    • 16.3.14. Avance Clinical
      • 16.3.14.1. Company Overview
      • 16.3.14.2. Financial Overview
      • 16.3.14.3. Product Portfolio
      • 16.3.14.4. Business Strategies
      • 16.3.14.5. Recent Developments
    • 16.3.15. Pharmaron
      • 16.3.15.1. Company Overview
      • 16.3.15.2. Financial Overview
      • 16.3.15.3. Product Portfolio
      • 16.3.15.4. Business Strategies
      • 16.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Service Type, 2020-2035
  • Table 02: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 03: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 04: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 05: Global Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Region, 2020-2035
  • Table 06: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country, 2020-2035
  • Table 07: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 08: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 09: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 10: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 11: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 12: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 13: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 14: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 15: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 16: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 17: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 18: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 19: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 20: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 21: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 22: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 23: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 24: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 25: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035
  • Table 26: Middle East & Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035
  • Table 27: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Type, 2020-2035
  • Table 28: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by Therapeutic Area, 2020-2035
  • Table 29: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, By Application, 2020-2035
  • Table 30: Middle East and Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, by End-user, 2020-2035

List of Figures

  • Figure 01: Global Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 02: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 03: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Laboratory Services, 2020-2035
  • Figure 04: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Bioanalytical Testing Services, 2020-2035
  • Figure 05: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Decentralized Clinical Trial Services, 2020-2035
  • Figure 06: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Patient Recruitment, 2020-2035
  • Figure 07: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Site Identification, 2020-2035
  • Figure 08: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Analytical Testing Services, 2020-2035
  • Figure 09: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Clinical Trial Supply & Logistic Services, 2020-2035
  • Figure 10: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Protocol Designing, 2020-2035
  • Figure 11: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Clinical Trial Data Management Services, 2020-2035
  • Figure 12: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Medical Device Testing Services, 2020-2035
  • Figure 13: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 14: Global Clinical Trials Outsourcing Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
  • Figure 15: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2025-2035
  • Figure 16: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Oncology, 2020-2035
  • Figure 17: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Infectious Diseases, 2020-2035
  • Figure 18: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Neurology, 2020-2035
  • Figure 19: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Metabolic Disorders, 2020-2035
  • Figure 20: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Immunology, 2020-2035
  • Figure 21: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Cardiology, 2020-2035
  • Figure 22: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Genetic Diseases, 2020-2035
  • Figure 23: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Women's Health, 2020-2035
  • Figure 24: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 25: Global Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 26: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 27: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Small Molecules, 2020-2035
  • Figure 28: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Monoclonal Antibodies, 2020-2035
  • Figure 29: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Vaccine, 2020-2035
  • Figure 30: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Cell & Gene Therapy, 2020-2035
  • Figure 31: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Others, 2020-2035
  • Figure 32: Global Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 33: Global Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 34: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Pharmaceutical and Biotech Companies, 2020-2035
  • Figure 35: Global Clinical Trials Outsourcing Market Revenue (US$ Mn), by Medical Device Manufacturers, 2020-2035
  • Figure 36: Global Clinical Trials Outsourcing Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 37: Global Clinical Trials Outsourcing Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 38: North America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 39: North America Clinical Trials Outsourcing Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 40: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 41: North America Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 42: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 43: North America Clinical Trials Outsourcing Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
  • Figure 44: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Therapeutic Area, 2025-2035
  • Figure 45: North America Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 46: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 47: North America Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 48: North America Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 49: Europe Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 50: Europe Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 51: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 52: Europe Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 53: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 54: Europe Clinical Trials Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 55: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 56: Europe Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 57: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 58: Europe Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 59: Europe Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 60: Asia Pacific Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 61: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 62: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 63: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 64: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 65: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 66: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 67: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 68: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 69: Asia Pacific Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 70: Asia Pacific Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 71: Latin America Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 72: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 73: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 74: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 75: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 76: Latin America Clinical Trials Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 77: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 78: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 79: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 80: Latin America Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 81: Latin America Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035
  • Figure 82: Middle East & Africa Clinical Trials Outsourcing Market Value (US$ Mn) Forecast, 2020-2035
  • Figure 83: Middle East & Africa Clinical Trials Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 84: Middle East & Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 85: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by Service Type, 2024 and 2035
  • Figure 86: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by Service Type, 2025-2035
  • Figure 87: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
  • Figure 88: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025-2035
  • Figure 89: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by Application, 2024 and 2035
  • Figure 90: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by Application, 2025-2035
  • Figure 91: Middle East and Africa Clinical Trials Outsourcing Market Value Share Analysis, by End-user, 2024 and 2035
  • Figure 92: Middle East and Africa Clinical Trials Outsourcing Market Attractiveness Analysis, by End-user, 2025-2035